QCI Interpret for Oncology

Comprehensive Molecular Tumor Analysis with Alacris Theranostics

219 views
March 09, 2023
Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choices. However, deeper molecular insights are needed to improve personalized treatment decisions. Integrating gene expression analysis in personalized oncology provides an additional level of insight. These analyses include evaluating expressed mutations and drug targets, novel gene fusions, clinically relevant signatures, and the tumor immune microenvironment (TME).

Alacris Theranostics developed the Comprehensive Molecular Tumor Analysis (CMTA), a NGS-based tumor diagnostic test. The test integrates whole exome and transcriptomic sequencing (WES and RNAseq). The test deploys as an end-to-end accredited diagnostic platform from tumor sample uptake (FFPE or frozen) to personalized clinical interpretation reports.  CMTA is a tumor-agnostic test that displays a unique molecular view of each sample. CMTA is a useful approach for refractory cancers with complex patterns or tumors of unknown origin.

In this webinar, viewers will:

Learn about the strategy implemented in Alacris’ bioinformatics pipeline to identify cancer-relevant somatic events
Learn how Alacris uses QCI Interpret for Oncology to annotate variants and identify potential therapies
Be eligible for a complimentary QCI Interpret demo and sample report

Related videos

QCI Interpret for Oncology

How to scale-up comprehensive genomic profiling and deliver confident variant interpretations...

79 views November 10, 2023

As gene panels increase in size, comprehensive genomic profiling and variant...

Real-World Insights

Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...

134 views October 31, 2023

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...

QCI Interpret for Oncology

Scale your comprehensive genomic profiling workflow with superior automated variant interpretation

145 views June 28, 2023

Automating and scaling a comprehensive genomic profiling workflow can be a...

QCI Interpret for Oncology

FASTQ to final report: Ultra-fast workflow for CGP

336 views July 21, 2022

As our molecular knowledge of cancer continually evolves, a new era in cancer...